Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02615743 · ClinicalTrials.gov registry record · NA
Asthma Controller Adherence After Hospitalization
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT02615743 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 41 participants.
The verdict
NCT02615743, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study sets out to assess whether daily text message reminders help to enhance the consistency of use of controller medications following hospitalization for pediatric asthma patients ages 4-11 and their families. Text message reminders will be delivered to a subject's cell phone for those in the intervention group and electronic monitors will placed on the controller inhalers at the time of hospital discharge to track medication use over time in both the intervention and the regular care group. Families will complete surveys on the day of enrollment (in person), day 30 (telephone) and day 60 (telephone) on aspects of asthma care including asthma knowledge, medication routines, who is responsible for asthma care, and medication beliefs.
Interventions
- BEHAVIORAL Daily Text message reminder
- DEVICE Inhaled steroid canister monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2015-12 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02615743
The ClinicalTrials.gov registry entry for NCT02615743 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Daily Text message reminder is the first listed.
NCT02615743 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02615743 about?
NCT02615743 is a clinical study titled "Asthma Controller Adherence After Hospitalization". This study sets out to assess whether daily text message reminders help to enhance the consistency of use of controller medications following hospitalization for pediatric asthma patients ages 4-11 and their families. Text message reminders will be delivered to a subject's cell phone for those in th...
What is the current status of trial NCT02615743?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2015-12. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02615743?
The interventions under investigation include: Daily Text message reminder (BEHAVIORAL), Inhaled steroid canister monitor (DEVICE).
Who is sponsoring clinical trial NCT02615743?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.